£117.45

Wiley-Blackwell Precision Cancer Therapies, Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice: 1 (Precision Cancer Therapies, Volume 1)

9781119819929

Price data last checked 48 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£117 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 43 days • 43 data points (No recent data available)

Historical
Generating forecast...
£123.29 £116.87 £118.27 £119.67 £121.07 £122.47 £123.87 13 March 2026 23 March 2026 03 April 2026 13 April 2026 24 April 2026

Price Distribution

Price distribution over 43 days • 2 price levels

Days at Price
Current Price
32 days · current 11 days 0 8 16 24 32 £117 £123 Days at Price

Price Analysis

Most common price: £117 (32 days, 74.4%)

Price range: £117 - £123

Price levels: 2 different prices over 43 days

Description

Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies A thorough compilation of the many scientific breakthroughs in the ongoing development of precision cancer therapies related to lymphoma Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice focuses on lymphoma, an area which has seen a remarkable number of breakthroughs in the ongoing development of precision cancer therapies. Each section on a specific biology or class of drugs has an introductory chapter written by an authority in the field, exclusively focused on the science and its relevance to cancer biology. This approach addresses the need for scientists, physicians, and the private sector to understand the broader context of the extraordinary advances that have produced such astonishing advances in the disease. The work primarily focuses on how to understand and translate fundamental principles of basic science into information that can be directly applied to patients – hence the subtitle, From Concept to Practice. To aid in readers’ comprehension, the first page of each chapter contains a box entitled ‘Take Home Points’. This short text will highlight the major unique points about the information contained within the chapter. Some of the key topics addressed in the work are as follows: Biological basis of the lymphoid malignancies: fundamental principles of lymphomagenesis and molecular classification of lymphoid malignancies Targeting programmed cell death: principles for understanding the many types of cell death and promising combinations of drugs targeting apoptosis Targeting the PI3K pathway: understanding the intricacies of this complex biology and precisely how targeted drugs can be leveraged therapeutically Targeting the cancer epigenome: pharmacologic features of drugs targeting the epigenome and future prospects for targeting various aspects of epigenetic control Targeting the tumour proteome: understanding the mechanisms of protein degradation in cancer including both older drugs like proteasome inhibitors, and newer PROTAC based approaches Written primarily for scientists and physicians in both the public and private sectors, Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice is a comprehensive reference work for those interested in the growing area of Precision Cancer Therapies. Seamlessly integrating the basic and applied science, this volume will be an indispensable reference for those interested in translating the most important advances in science to innovative novel treatments for patients.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Targeted Therapies in Oncology
97% match

Targeted Therapies in Oncology

CRC Press

£56.99 20 Feb 2026
Cancer Epigenetics for Precision Medicine: Methods and Protocols: 1856 (Methods in Molecular Biology, 1856)
97% match

Cancer Epigenetics for Precision Medicine: Methods and Protocols: 1856 (Methods in Molecular Biology, 1856)

Humana

£117.75 10 Feb 2026
Targeted Therapies in Oncology
97% match

Targeted Therapies in Oncology

CRC Press

£111.28 04 May 2026
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics
97% match

Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics

Oxford University Press

£42.99 11 Jun 2026
Advances In Precision Medicine: Insights From Oncology Research And Clinical Applications
97% match

Advances In Precision Medicine: Insights From Oncology Research And Clinical Applications

£148.14 11 Feb 2026
Mutant p53 and MDM2 in Cancer: 85 (Subcellular Biochemistry, 85)
97% match

Mutant p53 and MDM2 in Cancer: 85 (Subcellular Biochemistry, 85)

Springer

£95.76 23 Apr 2026
Springer Mutant p53 and MDM2 in Cancer - Subcellular Biochemistry 85
97% match

Springer Mutant p53 and MDM2 in Cancer - Subcellular Biochemistry 85

Springer

£112.81 30 Apr 2026
Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)
97% match

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Academic Press

£111.19 10 Mar 2026
Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)
97% match

Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)

Springer

£128.11 19 Apr 2026
Cellular Cancer Markers: 12 (Contemporary Biomedicine, 12)
97% match

Cellular Cancer Markers: 12 (Contemporary Biomedicine, 12)

Humana

£67.69 01 May 2026
TCTP/tpt1 - Remodeling Signaling from Stem Cell to Disease: 64 (Results and Problems in Cell Differentiation)
97% match

TCTP/tpt1 - Remodeling Signaling from Stem Cell to Disease: 64 (Results and Problems in Cell Differentiation)

Springer

£116.88 11 Jun 2026
Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)
97% match

Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)

Springer

£110.00 10 Mar 2026
Pediatric Neoplasia: Advances in Molecular Pathology and Translational Medicine (Molecular and Translational Medicine)
97% match

Pediatric Neoplasia: Advances in Molecular Pathology and Translational Medicine (Molecular and Translational Medicine)

Humana

£79.93 22 Feb 2026
Hsp90 in Cancer: Beyond the Usual Suspects (Volume 129) (Advances in Cancer Research, Volume 129)
97% match

Hsp90 in Cancer: Beyond the Usual Suspects (Volume 129) (Advances in Cancer Research, Volume 129)

Academic Press

£110.59 10 Mar 2026
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology, 2108)
97% match

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology, 2108)

Humana

£92.38 23 Feb 2026
Cancer Biology
97% match

Cancer Biology

Oxford University Press

£69.50 27 Feb 2026
Advances in Molecular Pathology, 2018 (Volume 1-1) (Advances, Volume 1-1)
97% match

Advances in Molecular Pathology, 2018 (Volume 1-1) (Advances, Volume 1-1)

Elsevier

£112.64 09 Mar 2026
Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)
97% match

Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)

Humana

£141.36 10 Mar 2026
Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)
97% match

Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)

Humana

£74.07 07 Mar 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
97% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.48 18 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
97% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£108.91 20 Apr 2026
Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)
97% match

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Springer

£87.81 18 Apr 2026
Handbook of Targeted Cancer Therapy and Immunotherapy
97% match

Handbook of Targeted Cancer Therapy and Immunotherapy

WOLTERS KLUWER HEALTH

£54.06 20 Feb 2026
Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)
97% match

Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)

Humana

£73.10 30 Apr 2026